These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 38702206)

  • 21. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
    Nimkuntod P; Tongdee P
    J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New atherogenic index for the prediction of carotid atherosclerosis based on the non-ultrasensitive c-reactive protein/HDL ratio.
    Fabregat-Andrés Ó; Pérez-de-Lucía P; Vallejo-García VE; Vera-Ivars P; Valverde-Navarro AA; Tormos JM
    Clin Investig Arterioscler; 2024; 36(1):12-21. PubMed ID: 37625908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
    Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
    Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association between venous thrombosis and dyslipidemia].
    García Raso A; Ene G; Miranda C; Vidal R; Mata R; Llamas Sillero MP
    Med Clin (Barc); 2014 Jul; 143(1):1-5. PubMed ID: 24183115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relación entre el índice lipoproteínas de baja densidad (LDL)/lipoproteínas de alta densidad (HDL) con enzimas antioxidantes y el índice oxLDL/HDL.
    Zamora-Ginez I; Baez-Duarte BG; Nieva-Vazquez A; García-Aragón KH; Monjaraz-Guzmán E; Mendoza-Carrera F; Meneses-Zamora P; Flores-Blanco CV; Luna-De Jesús K
    Gac Med Mex; 2019; 155(5):487-492. PubMed ID: 31695237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.
    Josefs T; Wouters K; Tietge UJF; Annema W; Dullaart RPF; Vaisar T; Arts ICW; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG; Goldberg IJ; Fisher EA; van Greevenbroek MMJ
    J Clin Lipidol; 2020; 14(1):122-132.e4. PubMed ID: 31791716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle-related risk factors, smoking status and cardiovascular disease.
    Giudice R; Izzo R; Manzi MV; Pagnano G; Santoro M; Rao MA; Di Renzo G; De Luca N; Trimarco V
    High Blood Press Cardiovasc Prev; 2012 Jun; 19(2):85-92. PubMed ID: 22867094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Lipid Levels With the Prevalence of Hypertension in Chinese Women: A Cross-Sectional Study Based on 32 Health Check Centers.
    Deng G; Li Y; Cheng W
    Front Endocrinol (Lausanne); 2022; 13():904237. PubMed ID: 35873005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis.
    Tamada M; Makita S; Abiko A; Naganuma Y; Nagai M; Nakamura M
    Metabolism; 2010 May; 59(5):653-7. PubMed ID: 19913853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).
    Aroner SA; Koch M; Mukamal KJ; Furtado JD; Stein JH; Tattersall MC; McClelland RL; Jensen MK
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial.
    Lakshmanan S; Shekar C; Kinninger A; Dahal S; Onuegbu A; Cai AN; Hamal S; Birudaraju D; Cherukuri L; Flores F; Dailing C; Roy SK; Bhatt DL; Nelson JR; Budoff MJ
    Atherosclerosis; 2020 Jul; 305():34-41. PubMed ID: 32615321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Related cardiometabolic factors and prevalence of low HDL-cholesterol levels and atherogenic dyslipidemia. SIMETAP-AD study.
    Ruiz-García A; Arranz-Martínez E; García-Fernández ME; Cabrera-Vélez R; García-Pliego RA; Morales-Cobos LE; Sanz-Pozo B; Gómez-Díaz E; Rodríguez-de-Mingo E; Rico-Pérez MR; Migueláñez-Valero A; Calderín-Morales MP; Sandín-de-Vega E; Hombrados-Gonzalo MP; Luna-Ramírez S; Sánchez-Ramos MC; Mora-Casado C; Moreno-Muñoz MS; González-Escobar P; Ruiz-Díaz L; Caballero-Ramírez N; Zamora-Gómez MM; Iturmendi-Martínez N; Holgado-Catalán MS; Álvarez-Benedicto R; Sanchidriá-Fernández PL; Benito-Alonso E; Fernández-Vicente T; Hernández-López RM; Doria-Carlin NA; Frías-Vargas MJ;
    Clin Investig Arterioscler; 2021; 33(1):19-29. PubMed ID: 33082056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men. The Honolulu Heart Program.
    Burchfiel CM; Abbott RD; Sharp DS; Curb JD; Rodriguez BL; Yano K
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1356-64. PubMed ID: 8911274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations Between Life-Course Lipid Trajectories and Subclinical Atherosclerosis in Midlife.
    Yan Y; Li S; Liu Y; Guo Y; Fernandez C; Bazzano L; He J; Chen W
    JAMA Netw Open; 2022 Oct; 5(10):e2234862. PubMed ID: 36197664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early detection of asymptomatic carotid disease in patients with obliterative arteriosclerosis of the lower extremities].
    Rancić Z; Radak D; Stojanović D
    Srp Arh Celok Lek; 2002; 130(7-8):258-64. PubMed ID: 12585003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.